by Innovit Corporate Affairs | May 28, 2019 | Blog, Eudamed
As it prepares to meet new regulatory requirements in Europe, the medical device community is following developments regarding the European Database for Medical Devices (Eudamed). Most recently, the European Commission (EC) released three documents for Medical Device...
by Innovit Corporate Affairs | May 21, 2019 | Blog, UDI
Recently, the FDA issued the final guidance, “Unique Device Identification: Convenience Kits” to help clarify the FDA’s policy related to UDI considerations for medical procedure kits. The intent of this guidance is to ensure that the exception for UDI labeling of...
by Innovit Corporate Affairs | Feb 13, 2019 | Blog, MDR
A no-deal Brexit (a disaster to some or the chance trade on our own terms to others) means the UK would leave the European Union (EU) immediately on 29 March 2019, and there would be no agreements in place about what their relationship would be like in future. It...
by Innovit Corporate Affairs | Feb 12, 2019 | Blog, GDSN
The GS1 Global Forum, scheduled to kick-off next week on February 18, 2019 in Brussels – is GS1’s largest global annual event aimed at aligning the organization’s strategy while strengthening the GS1 staff around the world. The week offers great opportunities to...
by Innovit Corporate Affairs | Feb 7, 2019 | Blog, MDR
Innovit at GS1 UK Healthcare Conference, London Managing the wealth of available healthcare data allows health systems to create holistic views of patients, personalize treatments, improve communication and enhance health outcomes. Additionally, data continues...
